Tumor Ablation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029 Segmented By Technology Type (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, HIFU, Others), By Treatment Type (Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation), By Application (Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other), By Region and Competition

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Forecast Period

2025-2029

Market Size (2023)

USD 1.94 Billion

CAGR (2024-2029)

8.64%

Fastest Growing Segment

Radiofrequency Ablation

Largest Market

North America

Market Overview

Global Tumor Ablation Market was valued at USD 1.94 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.64% through 2029. The tumor ablation market refers to the segment of the healthcare industry focused on the development, production, and sale of medical devices and treatments that destroy cancerous tumors. This is achieved through various minimally invasive techniques, such as radiofrequency, microwave, laser, and cryoablation, that selectively kill tumor cells while minimizing damage to the surrounding healthy tissue. The market is driven by the increasing prevalence of cancer worldwide, technological advancements in ablation devices, and the growing preference for minimally invasive surgeries that offer quicker recovery times and lower risks of complications.

Key Market Drivers

Increasing Prevalence of Cancer

The growing prevalence of cancer is one of the key drivers of the Global Tumor Ablation market. Cancer is one of the major global health concerns, with the prevalence of various types of cancer increasing worldwide. In 2018, a total of 403,262 new kidney cancer cases and 175,098 related deaths were reported. The global incidence of ASR was 4.5 per 100,000 people, with a 12-fold variability worldwide. Factors such as aging population, unhealthy lifestyles, environmental factors, and genetic predisposition contribute to the rising incidence of cancer. As the number of cancer cases continues to grow, there is a greater demand for effective treatment options such as tumor ablation. Through tumor ablation there is minimally invasive treatment option for certain type of cancer. These procedures involve the destruction of tumors using various energy sources such as radiofrequency, microwave, ultrasound, or cryoablation. Compared to traditional open surgery, tumor ablation techniques are less invasive, resulting in shorter hospital stays, reduced complications, and quicker recovery times for patients. With the advancement in cancer screening and diagnostic technologies has led to early detection of tumors in many cases. Early-stage tumors are often more flexible to treatment and have higher success rates. Tumor ablation techniques can be utilized for localized tumors, allowing physicians to target and destroy cancer cells while preserving surrounding healthy tissue this anticipates in the growth of Global Tumor Ablation Market.

Development of New Ablation Technologies

The developments of new ablation technologies play an important role in driving the growth of Global Tumor Ablation Market. The development of new ablation technologies has led to improved treatment efficacy. Microwave ablation is a relatively new technique in which microwaves are transmitted through a specially adapted antenna inserted into the tumor. Continuous microwave motion of surrounding water molecules generates friction and heat, leading to cell death. These advancements allow for better targeting and destruction of tumor cells while minimizing damage to surrounding healthy tissues. For example, the use of advanced imaging techniques, such as magnetic resonance imaging (MRI) and ultrasound, in combination with ablation technologies enables real-time visualization and accurate tumor targeting, leading to more precise and effective treatments. The range of available treatment options to physician and patients expanded with the introduction of the new ablation technologies. Distinct technologies, such as radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation, and high-intensity focused ultrasound (HIFU), offer varying benefits and are suitable for different types and sizes of tumors. This expanded toolbox allows healthcare providers to tailor the treatment approach to each patient's specific needs, driving the growth of Global Tumor Ablation Market.

Shift Towards Minimally Invasive Treatments Drives the Market

The shift towards minimally invasive treatment plays a significant role in driving the growth of Global Tumor Ablation Market. There are several reasons because of patients increasingly prefer minimally invasive treatment options. Minimally invasive procedures typically involve smaller incisions, less scarring, reduced pain, shorter hospital stays, and quicker recovery times compared to traditional open surgery. These benefits contribute to improved patient experiences and satisfaction. As patient awareness and demand for minimally invasive treatments increase, the Global Tumor ablation Market experiences growth. Minimally invasive procedures can lead to cost savings in healthcare. These procedures often require shorter hospital stays and less post-operative care, resulting in lower healthcare costs for patients and healthcare systems. By providing an effective alternative to more invasive and costly treatment options, tumor ablation contributes to cost containment and healthcare expenditure reduction, thus driving market growth.

Expanding Healthcare Infrastructure Across Developing Nation

The expanding healthcare infrastructure across developing nations is significantly increasing the demand for tumor ablation procedures globally. Tumor ablation, a minimally invasive treatment option, involves the destruction of cancerous tumors using various techniques such as radiofrequency ablation, microwave ablation, and cryoablation. As healthcare infrastructure improves in developing nations, there is greater access to advanced medical technologies, skilled healthcare professionals, and specialized treatment facilities capable of performing tumor ablation procedures.

Moreover, as awareness of cancer and its treatment options grows, patients in these regions are increasingly seeking minimally invasive alternatives to traditional surgery or chemotherapy. Tumor ablation offers several advantages, including shorter recovery times, reduced risk of complications, and fewer hospital stays, making it an appealing option for both patients and healthcare providers. Consequently, the expanding healthcare infrastructure across developing nations is driving a surge in demand for tumor ablation procedures globally, as more individuals gain access to these life-saving treatments.


Download Free Sample Report

Key Market Challenges

High Cost of Treatments

The high cost of tumor ablation treatments presents a significant barrier, decreasing the demand for these procedures globally. While tumor ablation offers several advantages, including minimal invasiveness, shorter recovery times, and reduced risk of complications, the associated costs can be prohibitive for many patients. Tumor ablation procedures often require specialized equipment, advanced imaging technologies, and skilled healthcare professionals, all of which contribute to high treatment expenses.

Additionally, post-procedural care and follow-up appointments further add to the financial burden for patients. As a result, individuals facing cancer diagnoses may be deterred from pursuing tumor ablation treatments due to concerns about affordability, particularly in regions with limited healthcare coverage or where out-of-pocket expenses are high. Moreover, despite the potential long-term cost savings associated with tumor ablation compared to traditional treatments like surgery or chemotherapy, the upfront costs may still pose a significant financial barrier for many patients, leading to a decrease in demand for these procedures globally. Addressing the high cost of tumor ablation treatments is essential to ensure equitable access to this life-saving intervention for all individuals facing cancer diagnoses.

Lack of Awareness

The lack of awareness about tumor ablation procedures is a significant factor decreasing the demand for this treatment globally. Tumor ablation, a minimally invasive technique used to destroy cancerous tumors, offers several benefits such as shorter recovery times, reduced risk of complications, and improved quality of life for patients. However, despite its effectiveness, many individuals facing cancer diagnoses may be unaware of tumor ablation as a treatment option. This lack of awareness can stem from various factors, including limited access to information, insufficient education among healthcare providers and patients, and cultural or societal barriers that may influence perceptions of cancer treatment. Consequently, patients and healthcare providers may not consider tumor ablation as a viable treatment option, leading to underutilization of this potentially life-saving intervention.

Key Market Trends

Rise in Healthcare Expenditure & Disposable Income

The rise in healthcare expenditure and disposable income is significantly increasing the demand for tumor ablation procedures globally. As economies grow and disposable incomes increase, individuals are allocating more resources towards healthcare, including advanced medical treatments such as tumor ablation. Tumor ablation, a minimally invasive procedure used to treat cancerous tumors, offers several benefits such as reduced recovery times, fewer complications, and improved quality of life compared to traditional treatments like surgery or chemotherapy.

Additionally, as healthcare expenditure increases, healthcare systems are investing in advanced technologies and facilities capable of performing tumor ablation procedures, further driving the demand for these treatments. Moreover, with greater disposable income, patients are more willing and able to seek out innovative and effective treatment options, including tumor ablation, to address their healthcare needs. Consequently, the rise in healthcare expenditure and disposable income is fueling a surge in demand for tumor ablation procedures globally, as individuals prioritize their health and well-being.

Growing Number of Specialized Cancer Treatment Centers

The growing number of specialized cancer treatment centers is significantly increasing the demand for tumor ablation procedures globally. These centers, equipped with state-of-the-art technologies and staffed by skilled healthcare professionals, offer comprehensive cancer care services, including tumor ablation.

As the prevalence of cancer continues to rise globally, there is a corresponding increase in the need for specialized treatment centers capable of providing advanced therapies such as tumor ablation. These centers serve as hubs for cancer care, attracting patients from far and wide who seek access to cutting-edge treatments and personalized care. Additionally, the establishment of specialized cancer treatment centers often leads to collaborations with research institutions and industry partners, fostering innovation and advancements in tumor ablation techniques and technologies. Consequently, the growing number of specialized cancer treatment centers is driving a surge in demand for tumor ablation procedures globally, as patients seek out these centers for high-quality and specialized care to combat cancer.

Key Market Trends

Technology Type Insights

Based on the Technology Type, in the highly dynamic and competitive landscape of the Global Tumor Ablation Market, one technique that continues to stand out and maintain its leading position is Radiofrequency Ablation (RFA). The remarkable dominance of RFA can be attributed to a combination of factors that include its established efficacy, excellent safety profile, and remarkable applicability across a wide range of tumor types.  Moreover, what sets RFA apart from other techniques is its affordability, making it a cost-effective choice for healthcare professionals and patients alike. This affordability has further contributed to the widespread adoption of RFA, cementing its position as the preferred technique in the tumor ablation space.

With its proven track record, comprehensive applicability, and cost-effectiveness, Radiofrequency Ablation (RFA) continues to be the go-to choice for healthcare professionals seeking reliable and efficient tumor ablation solutions.

Treatment Type Insights

Based on the Treatment Type segment, in the dynamic and rapidly evolving landscape of the Global Tumor Ablation Market, Percutaneous Ablation has emerged as the leading technique. This minimally invasive procedure, known for its exceptional precision and shorter recovery period, has gained immense popularity among both physicians and patients alike. By significantly reducing the need for prolonged hospital stays, Percutaneous Ablation has proven to be a game-changer in the field of tumor treatment. Its remarkable effectiveness has been demonstrated across a wide range of tumor locations, solidifying its dominant position in the market. With its remarkable potential to revolutionize the way tumors are managed, Percutaneous Ablation is poised to shape the future of tumor ablation techniques.


Download Free Sample Report

Regional Insights

North America is emerging as the dominant player in the Global Tumor Ablation Market. This can be attributed to several key factors. First and foremost, the region boasts an advanced healthcare infrastructure that enables efficient diagnosis and treatment of cancer. Additionally, North America is home to several leading medical device companies that continuously innovate and develop cutting-edge technologies for tumor ablation. The region's proactive approach towards technology adoption further contributes to its dominance in this market.

Furthermore, the increasing investments in healthcare in North America have led to significant advancements in cancer treatment. This, coupled with the rising number of cancer patients, has fueled the demand for minimally invasive cancer treatment procedures such as tumor ablation. These procedures offer several benefits, including reduced pain, shorter recovery time, and improved patient outcomes. North America's dominance in the Global Tumor Ablation Market can be attributed to its advanced healthcare infrastructure, presence of leading medical device companies, robust rate of technology adoption, increasing healthcare investments, growing number of cancer patients, and the rising demand for minimally invasive cancer treatment procedures.

Recent Developments

  • In December 2022, Boston Scientific Corporation and Acotech Scientific Holdings Limited announced that Boston Scientific will acquire a controlling stake of up to 65% in Acotech, a Chinese medical technology company that specializes in a wide range of interventional solutions. This strategic move includes a partial proposal to acquire the procedural rights, with an offer price of HK$20 per share. At current exchange rates, the cash component of the offer amounts to approximately US$523 million, representing a 65% interest.
  • In February 2023, Johnson & Johnson, a global healthcare product manufacturer, completed its previously announced merger with Innovative Devices, Inc., a renowned manufacturer of surgical instruments and tools. The merger, valued at approximately $85 million, was finalized following the approval of the merger agreement by Innovative shareholders.
  • In July 2021, Bioventus Inc., a global leader in active healing innovation, announced its acquisition of Misonix, Inc., a provider of minimally invasive therapeutic ultrasound technology and regenerative medicine. The agreement involved a combination of cash and stock transactions, marking a significant milestone for both companies.

Key Market Players

  • Boston Scientific Corporation
  • Ethicon, Inc.
  • Galil Medical Inc.
  • Misonix Inc.
  • HealthTronics
  • Mermaid Medical
  • Theraclion
  • Chongqing Haifu Medical Technology Co., Ltd.
  • HS Hospital Service S.P.A
  • EDAP TMS S.A

By Technology Type

By Treatment Type

By Application

By Region

 
  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • Irreversible Electroporation Ablation
  • HIFU
  • Others
  • Surgical Ablation
  • Laparoscopic Ablation
  • Percutaneous Ablation
  • Kidney Cancer
  • Liver Cancer
  • Breast Cancer
  • Lung Cancer
  • Others
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

 

 

Report Scope:

In this report, the Global Tumor Ablation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Tumor Ablation Market, By Technology Type:

o   Radiofrequency Ablation

o   Microwave Ablation

o   Cryoablation

o   Irreversible Electroporation Ablation

o   HIFU

o   Others

  • Tumor Ablation Market, By Treatment Type:

o   Surgical Ablation

o   Laparoscopic Ablation

o   Percutaneous Ablation

  • Tumor Ablation Market, By Application:

o   Kidney Cancer

o   Liver Cancer

o   Breast Cancer

o   Lung Cancer

o   Others

  • Tumor Ablation Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE


Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Tumor Ablation Market.

Available Customizations:

Global Tumor Ablation market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Tumor Ablation Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.          Markets Covered

1.2.2.          Years Considered for Study

1.2.3.          Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validations

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Tumor Ablation Market Outlook

5.1.  Market Size & Forecast

5.1.1.          By Value

5.2.  Market Share & Forecast

5.2.1.          By Technology Type (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, HIFU, Others)

5.2.2.          By Treatment Type (Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation)

5.2.3.          By Application (Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Others)

5.2.4.          By Region

5.2.5.          By Company (2023)

5.3.  Market Map

5.3.1.          By Technology Type

5.3.2.          By Treatment Type

5.3.3.          By Application

5.3.4.          By Region

6.    North America Tumor Ablation Market Outlook

6.1.  Market Size & Forecast       

6.1.1.          By Value

6.2.  Market Share & Forecast

6.2.1.          By Technology Type

6.2.2.          By Treatment Type

6.2.3.          By Application

6.2.4.          By Country

6.3.  North America: Country Analysis

6.3.1.          United States Tumor Ablation Market Outlook

6.3.1.1.        Market Size & Forecast

6.3.1.1.1.           By Value

6.3.1.2.        Market Share & Forecast

6.3.1.2.1.           By Technology Type

6.3.1.2.2.           By Treatment Type

6.3.1.2.3.           By Application

6.3.2.          Canada Tumor Ablation Market Outlook

6.3.2.1.        Market Size & Forecast

6.3.2.1.1.           By Value

6.3.2.2.        Market Share & Forecast

6.3.2.2.1.           By Technology Type

6.3.2.2.2.           By Treatment Type

6.3.2.2.3.           By Application

6.3.3.          Mexico Tumor Ablation Market Outlook

6.3.3.1.        Market Size & Forecast

6.3.3.1.1.           By Value

6.3.3.2.        Market Share & Forecast

6.3.3.2.1.           By Technology Type

6.3.3.2.2.           By Treatment Type

6.3.3.2.3.           By Application

7.    Europe Tumor Ablation Market Outlook

7.1.  Market Size & Forecast       

7.1.1.          By Value

7.2.  Market Share & Forecast

7.2.1.          By Technology Type

7.2.2.          By Treatment Type

7.2.3.          By Application

7.2.4.          By Country

7.3.  Europe: Country Analysis

7.3.1.          United Kingdom Tumor Ablation Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.           By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.           By Technology Type

7.3.1.2.2.           By Treatment Type

7.3.1.2.3.           By Application

7.3.2.          Germany Tumor Ablation Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.           By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.           By Technology Type

7.3.2.2.2.           By Treatment Type

7.3.2.2.3.           By Application

7.3.3.          France Tumor Ablation Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.           By Value

7.3.3.2.        Market Share & Forecasty

7.3.3.2.1.           By Technology Type

7.3.3.2.2.           By Treatment Type

7.3.3.2.3.           By Application

7.3.4.          Italy Tumor Ablation Market Outlook

7.3.4.1.        Market Size & Forecast

7.3.4.1.1.           By Value

7.3.4.2.        Market Share & Forecast

7.3.4.2.1.           By Technology Type

7.3.4.2.2.           By Treatment Type

7.3.4.2.3.           By Application

7.3.5.          Spain Tumor Ablation Market Outlook

7.3.5.1.        Market Size & Forecast

7.3.5.1.1.           By Value

7.3.5.2.        Market Share & Forecast

7.3.5.2.1.           By Technology Type

7.3.5.2.2.           By Treatment Type

7.3.5.2.3.           By Application

8.    Asia-Pacific Tumor Ablation Market Outlook

8.1.  Market Size & Forecast       

8.1.1.          By Value

8.2.  Market Share & Forecast

8.2.1.          By Technology Type

8.2.2.          By Treatment Type

8.2.3.          By Application

8.2.4.          By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.          China Tumor Ablation Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.           By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.           By Technology Type

8.3.1.2.2.           By Treatment Type

8.3.1.2.3.           By Application

8.3.2.          India Tumor Ablation Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.           By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.           By Technology Type

8.3.2.2.2.           By Treatment Type

8.3.2.2.3.           By Application

8.3.3.          Japan Tumor Ablation Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.           By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.           By Technology Type

8.3.3.2.2.           By Treatment Type

8.3.3.2.3.           By Application

8.3.4.          South Korea Tumor Ablation Market Outlook

8.3.4.1.        Market Size & Forecast

8.3.4.1.1.           By Value

8.3.4.2.        Market Share & Forecast

8.3.4.2.1.           By Technology Type

8.3.4.2.2.           By Treatment Type

8.3.4.2.3.           By Application

8.3.5.          Australia Tumor Ablation Market Outlook

8.3.5.1.        Market Size & Forecast

8.3.5.1.1.           By Value

8.3.5.2.        Market Share & Forecast

8.3.5.2.1.           By Technology Type

8.3.5.2.2.           By Treatment Type

8.3.5.2.3.           By Application

9.    South America Tumor Ablation Market Outlook

9.1.  Market Size & Forecast       

9.1.1.          By Value

9.2.  Market Share & Forecast

9.2.1.          By Technology Type

9.2.2.          By Treatment Type

9.2.3.          By Application

9.2.4.          By Country

9.3.  South America: Country Analysis

9.3.1.          Brazil Tumor Ablation Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.           By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.           By Technology Type

9.3.1.2.2.           By Treatment Type

9.3.1.2.3.           By Application

9.3.2.          Argentina Tumor Ablation Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.           By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.           By Technology Type

9.3.2.2.2.           By Treatment Type

9.3.2.2.3.           By Application

9.3.3.          Colombia Tumor Ablation Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.           By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.           By Technology Type

9.3.3.2.2.           By Treatment Type

9.3.3.2.3.           By Application

10. Middle East and Africa Tumor Ablation Market Outlook

10.1.             Market Size & Forecast        

10.1.1.        By Value

10.2.             Market Share & Forecast

10.2.1.        By Technology Type

10.2.2.        By Treatment Type

10.2.3.        By Application

10.2.4.        By Country

10.3.             MEA: Country Analysis

10.3.1.        South Africa Tumor Ablation Market Outlook

10.3.1.1.     Market Size & Forecast

10.3.1.1.1.         By Value

10.3.1.2.     Market Share & Forecast

10.3.1.2.1.         By Technology Type

10.3.1.2.2.         By Treatment Type

10.3.1.2.3.         By Application

10.3.2.        Saudi Arabia Tumor Ablation Market Outlook

10.3.2.1.     Market Size & Forecast

10.3.2.1.1.         By Value

10.3.2.2.     Market Share & Forecast

10.3.2.2.1.         By Technology Type

10.3.2.2.2.         By Treatment Type

10.3.2.2.3.         By Application

10.3.3.        UAE Tumor Ablation Market Outlook

10.3.3.1.     Market Size & Forecast

10.3.3.1.1.         By Value

10.3.3.2.     Market Share & Forecast

10.3.3.2.1.         By Technology Type

10.3.3.2.2.         By Treatment Type

10.3.3.2.3.         By Application

11. Market Dynamics

11.1.             Drivers

11.2.             Challenges

12. Market Trends & Developments

12.1.             Recent Development

12.2.             Mergers & Acquisitions

12.3.             Product Launches

13. Global Tumor Ablation Market: SWOT Analysis

14. Porter’s Five Forces Analysis

14.1.             Competition in the Industry

14.2.             Potential of New Entrants

14.3.             Power of Suppliers

14.4.             Power of Customers

14.5.             Threat of Substitute Products

15. Competitive Landscape

15.1.             Boston Scientific Corporation

15.1.1.        Business Overview

15.1.2.        Product Offerings

15.1.3.        Recent Developments

15.1.4.        Key Personnel

15.1.5.        SWOT Analysis

15.2.             Ethicon, Inc.

15.3.             Galil Medical Inc.

15.4.             Misonix Inc.

15.5.             HealthTronics Inc.

15.6.             Mermaid Medical

15.7.             Theraclion SA

15.8.             Chongqing Haifu Medical Technology Co., Ltd.

15.9.             HS Hospital Service S.P.A

15.10.          EDAP TMS S.A

16.  Strategic Recommendations

17.  About Us & Disclaimer

Figures and Tables

Frequently asked questions

down-arrow

The market size of the Global Tumor Ablation Market was estimated to be USD 1.94 Billion in 2023.

down-arrow

Percutaneous Ablation leads the Global Tumor Ablation Market with its precision, minimal invasiveness, and shorter recovery time. This preferred choice of physicians and patients reduces hospital stays and effectively treats tumors in various locations.

down-arrow

North America currently leads the Global Tumor Ablation Market, driven by advanced healthcare infrastructure, prominent medical device companies, and rapid technology adoption. Factors such as increased healthcare investments, rising cancer cases, and demand for minimally invasive cancer treatments contribute to this trend.

down-arrow

Increasing prevalence of cancer and development of new ablation technologies are the major drivers for the Global Tumor Ablation Market.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Tumor Ablation Market to Grow at 8.64% CAGR over 2025 to 2029

Feb, 2024

Rise in healthcare expenditure & disposable income and growing number of specialized cancer treatment centers is expected to drive the Global Tumor Ablation Market growth in the forecast period, 2025

Why Choose Us